III-21," a randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of bovhyaluronidase azoximer in adult patients with pulmonary sequelae of COVID-19.

A mysterious illness in the Democratic Republic of Congo, initially feared to be "Disease X," has likely been identified as ...

Petrovax has announced positive results stemming from the Long-CoV-III-21 trial, which tested the efficacy of bovhyaluronidase azoximer (Longidaza) in patients with long-term COVID-19 pulmonary ...

III-21," a randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of bovhyaluronidase azoximer in adult patients with pulmonary sequelae of COVID-19. Bovhyaluronidase ...

Respiratory illnesses, including RSV, flu, and COVID-19, are surging across the US, particularly impacting young children in ...

In this Review, we examine the concurrent outbreaks of mpox in Africa, focusing on clade 1a, the newly emerged clade 1b, and ...

BENGALURU: A study by the Indian Institute of Science (IISc) has revealed why viruses like SARS-CoV-2, which originate in ...

If you have been diagnosed with advanced emphysema, also called COPD, EBV treatment might be an option for you. Patients living with emphysema experience shortness of breath because areas within the ...

COLD AND FLU VIRUSES have been making people sneeze and hack for millennia. Ancient Egyptians described a flu-like illness on ...